7 Growth inhibitors in haemopoiesis and leukaemogenesis
- 16 September 1997
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Haematology
- Vol. 10 (3) , 539-559
- https://doi.org/10.1016/s0950-3536(97)80025-x
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- Identification of a major co-receptor for primary isolates of HIV-1Nature, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Requirement of Mip-1α for an Inflammatory Response to Viral InfectionScience, 1995
- The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanismBlood, 1994
- Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.Molecular and Cellular Biology, 1994
- Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis.The Journal of Experimental Medicine, 1994
- Transforming growth factor-β 1 as a signal for induction of cell death by apoptosisBritish Journal of Cancer, 1993
- Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cellsBlood, 1990
- Physicochemical Activation of Recombinant Latent Transforming Growth Factor-beta's 1, 2, and 3Growth Factors, 1990